Taken together, our data strongly suggest that NADPH oxidase-derived ROS convey cell survival signals in MV3 melanoma cells through the persistent activation of the FAK pathway, probably inhibiting protein tyrosine phosphatase activity. The gene discussed is FMO5; the disease is melanoma.